putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)

ResearcherPublications, citations & collaboration network

putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) have?

ScholarIQindexed works

putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) has 1 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) →

How many citations does putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) have?

ScholarIQcitation count

putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) has 3 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) →

What is the h-index of putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)?

ScholarIQh-index

putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) has an h-index of 1 in OpenAlex.

Open the OpenAlex record →

What is the i10-index of putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)?

ScholarIQi10-index

putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) has an i10-index of 0 in OpenAlex.

Open the OpenAlex record →

What is the OpenAlex record for putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)?

ScholarIQopenalex

The OpenAlex for putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21) is on the source record.

Open the OpenAlex →

What are the most-cited papers on putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)?

ScholarIQmost cited works

Oral Abstract

Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are chemogenetic tools for remote control of targeted cell populations using chemical actuators that bind to modified receptors. Despite the popularity of DREADDs in neuroscience and sleep research, potential effects of clozapine-N-oxide (CNO) and other DREADD actuators on sleep have never been systematically tested. Recent reports suggest that CNO can affect brain activity and animal behaviour, putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21), a novel actuator that cannot convert to clozapine, affect sleep in wild type laboratory mice.

Journal of Sleep Research. 20223 CitationsOPEN ACCESS